PAX5 and lymphoma: The lower levels of PAX5 in DLBCL tissues compared with FL tissues further indicate that the microenvironment in aggressive lymphomas may be less supportive of normal B-cell differentiation, potentially contributing to immune evasion and poorer response to therapy.